Rick Wise
Stock Analyst at Stifel Nicolaus
(2.50)
# 3,111
Out of 4,693 analysts
799
Total ratings
51.2%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Hold | $80 → $95 | $92.04 | +3.22% | 51 | Sep 2, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $40 → $45 | $50.43 | -10.77% | 7 | Aug 14, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Buy | $195 | $187.12 | +4.21% | 33 | Aug 11, 2026 | |
| TMCI Treace Medical Concepts | Maintained: Hold | $3 → $4.5 | $4.60 | -2.17% | 25 | Aug 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $27.09 | +66.11% | 21 | Aug 7, 2026 | |
| TSX: PRN Profound Medical Corp. | Maintained: Buy | $13.86 | $9.45 | +46.69% | 11 | Aug 7, 2026 | |
| OM Outset Medical | Reiterated: Buy | $6 | $3.64 | +64.84% | 31 | Aug 7, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Buy | $105 → $110 | $99.40 | +10.66% | 48 | Aug 6, 2026 | |
| SOLV Solventum | Maintained: Buy | $90 → $100 | $90.95 | +9.95% | 12 | Aug 6, 2026 | |
| MDLN Medline | Rated: Buy | $50 → $45 | $35.11 | +28.17% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $81.08 | +48.00% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $85 | $80.16 | +6.04% | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $23.00 | +4.35% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $28 | $25.48 | +9.89% | 37 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 | $2.24 | +11.61% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $70.42 | +13.60% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $60 | $48.08 | +24.79% | 67 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $48.92 | +2.21% | 35 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $90.74 | +21.23% | 51 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $670 → $550 | $369.25 | +48.95% | 49 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $250 → $260 | $271.19 | -4.13% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $25.12 | +19.43% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $440 → $360 | $317.40 | +13.42% | 34 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $108.93 | +10.16% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 | $49.12 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.0001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.17 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $34 | $21.28 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $545.16 | n/a | 2 | Nov 8, 2012 |
Medtronic
Sep 2, 2026
Maintained: Hold
Price Target: $80 → $95
Current: $92.04
Upside: +3.22%
HeartFlow
Aug 14, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $50.43
Upside: -10.77%
Becton, Dickinson and Company
Aug 11, 2026
Maintained: Buy
Price Target: $195
Current: $187.12
Upside: +4.21%
Treace Medical Concepts
Aug 11, 2026
Maintained: Hold
Price Target: $3 → $4.5
Current: $4.60
Upside: -2.17%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $27.09
Upside: +66.11%
Profound Medical Corp.
Aug 7, 2026
Maintained: Buy
Price Target: $13.86
Current: $9.45
Upside: +46.69%
Outset Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $3.64
Upside: +64.84%
Zimmer Biomet Holdings
Aug 6, 2026
Rated: Buy
Price Target: $105 → $110
Current: $99.40
Upside: +10.66%
Solventum
Aug 6, 2026
Maintained: Buy
Price Target: $90 → $100
Current: $90.95
Upside: +9.95%
Medline
Aug 6, 2026
Rated: Buy
Price Target: $50 → $45
Current: $35.11
Upside: +28.17%
Aug 5, 2026
Maintained: Buy
Price Target: $120
Current: $81.08
Upside: +48.00%
Aug 5, 2026
Maintained: Buy
Price Target: $80 → $85
Current: $80.16
Upside: +6.04%
Aug 5, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $23.00
Upside: +4.35%
Jul 31, 2026
Maintained: Hold
Price Target: $19 → $28
Current: $25.48
Upside: +9.89%
Jul 30, 2026
Maintained: Buy
Price Target: $2.5
Current: $2.24
Upside: +11.61%
Jul 30, 2026
Maintained: Buy
Price Target: $80
Current: $70.42
Upside: +13.60%
Jul 29, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $48.08
Upside: +24.79%
Jul 24, 2026
Maintained: Buy
Price Target: $50
Current: $48.92
Upside: +2.21%
Jul 24, 2026
Maintained: Buy
Price Target: $110
Current: $90.74
Upside: +21.23%
Jul 17, 2026
Rated: Buy
Price Target: $670 → $550
Current: $369.25
Upside: +48.95%
Jul 15, 2026
Maintained: Hold
Price Target: $250 → $260
Current: $271.19
Upside: -4.13%
Jul 15, 2026
Maintained: Buy
Price Target: $30
Current: $25.12
Upside: +19.43%
May 1, 2026
Maintained: Buy
Price Target: $440 → $360
Current: $317.40
Upside: +13.42%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $108.93
Upside: +10.16%
May 1, 2025
Maintained: Hold
Price Target: $55
Current: $49.12
Upside: n/a
Jun 3, 2023
Maintained: Hold
Price Target: $1
Current: $0.0001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $2.17
Upside: n/a
Aug 22, 2018
Maintained: Hold
Price Target: $25 → $34
Current: $21.28
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $545.16
Upside: n/a